Revive Therapeutics Ltd. (RVV.CX)
0.025
0.00 (0.00%)
CAD |
CNSX |
Aug 27, 16:00
Revive Therapeutics Debt to Equity Ratio : -0.0176 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.0176 |
| December 31, 2025 | -0.0186 |
| September 30, 2025 | -0.0195 |
| June 30, 2025 | -0.0194 |
| March 31, 2025 | 0.011 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.0035 |
| March 31, 2024 | 0.0063 |
| December 31, 2023 | 0.0101 |
| September 30, 2023 | 0.0126 |
| June 30, 2023 | 0.015 |
| March 31, 2023 | 0.0159 |
| December 31, 2022 | 0.0227 |
| September 30, 2022 | 0.022 |
| June 30, 2022 | 0.0212 |
| March 31, 2022 | 0.0193 |
| December 31, 2021 | 0.0149 |
| September 30, 2021 | 0.0139 |
| June 30, 2021 | 0.0124 |
| March 31, 2021 | 0.012 |
| December 31, 2020 | 0.0398 |
| September 30, 2020 | 0.0437 |
| June 30, 2020 | 0.0573 |
| March 31, 2020 | 0.098 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.9295 |
| September 30, 2019 | 0.7127 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| HLS Therapeutics, Inc. | 0.7586 |
| Bausch Health Cos., Inc. | -11.73 |
| Cipher Pharmaceuticals, Inc. | 0.0027 |
| BioSyent, Inc. | 0.0685 |
| Knight Therapeutics, Inc. | 0.0429 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.2818M |
| Total Liabilities (Quarterly) | 4.306M |
| Shareholders Equity (Quarterly) | -4.025M |
| Current Ratio | 0.0359 |
| Net Debt Paydown Yield | -0.09% |